Panacea Biotec Ltd

NSE: PANACEABIO · BSE: 531349 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹357.10
Market cap: ₹2,187 Cr
Revenue (annual): ₹639.8 Cr
Net profit (annual): ₹-5.37 Cr
P/E (TTM): -307.2×Sector 47.4×
Promoter holding: 72.48%+0.00% QoQ
FII holding: 2.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 6 Promoter Buying (Off-Market) 3 Other Announcement 3 New Order Win 3 Financial Results 3 Board Meeting Date 2 Management Change 1 Capital Structure Change 1 Annual General Meeting 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 May 2026 16:19 IST NSE

Management Change

Panacea Biotec Management Change

Panacea Biotec announced director appointments at its material subsidiary, Panacea Biotec Pharma Limited. These leadership changes aim to strengthen governance and ensure ethical board practices.

Execution: July 01, 2026 to February 13, 2030 (Jalan); 5 years (Upadhyay)

Read the filing ↗